Antiviral treatment comprising Blis containing probiotic products
AssigneeBlis Technologies Limited
InventorsJohn David Francis Hale, John Robert Tagg
Life of this patent
Estimating the term…
Abstract
This invention relates to methods of prophylactically or therapeutically treating viral infections particularly in the lower respiratory tract. Treatment of coronavirus infections is particularly contemplated. The invention also relates to the use of BLIS-producing Streptococcus strains, extracts and exudates thereof, and compositions containing same in the prevention, reduction, or treatment of such virus infections.
Claims22
A method for a prophylactic or therapeutic treatment of a lower respiratory tract (LRT) virus infection in a patient in need thereof, the method comprising administering to said patient an effective amount of a Blis product,
- wherein the LRT virus is selected from the group consisting of influenza A, influenza B, respiratory syncytial virus (RSV), and coronavirus, and
- wherein the Blis product is selected from the group consisting of S. salivarius strain K12, S. salivarius strain M18, S. salivarius strain DC0010A, S. salivarius strain Glasgow 3, exudates thereof, extracts thereof, and supernatants thereof.
Dependencies are inferred from the claim text.